Finally, increased interferon (IFN) gamma signaling leads to upregulation of PD-1 on host T cells and PD-L1 on tumor cells, resulting in an augmented antineoplastic effect when combined with PD-1 blockade [91] (Figure 2). The gene discussed is PDCD1; the disease is neoplasm.